The role of haemorheological factors in the ageing brain : long-term therapy with pentoxifylline ('Trental' 400) in elderly patients with initial mental deterioration

Sixty elderly patients suffering from initial mental deterioration (less than 6 months) were divided at random into two groups, homogeneous for age, sex and life habits. For 28 weeks Group I was given a placebo and Group II was given 400 mg pentoxifylline ('Trental' 400) 3-times daily for...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 4(1986), 10 vom: 02., Seite 617-27
1. Verfasser: Parnetti, L (VerfasserIn)
Weitere Verfasser: Ciuffetti, G, Mercuri, M, Lupattelli, G, Senin, U
Format: Aufsatz
Sprache:English
Veröffentlicht: 1986
Zugriff auf das übergeordnete Werk:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Schlagworte:Clinical Trial Journal Article Randomized Controlled Trial Theobromine OBD445WZ5P Pentoxifylline SD6QCT3TSU
LEADER 01000naa a22002652 4500
001 NLM035832762
003 DE-627
005 20231221133710.0
007 tu
008 231221s1986 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0120.xml 
035 |a (DE-627)NLM035832762 
035 |a (NLM)3602014 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Parnetti, L  |e verfasserin  |4 aut 
245 1 4 |a The role of haemorheological factors in the ageing brain  |b long-term therapy with pentoxifylline ('Trental' 400) in elderly patients with initial mental deterioration 
264 1 |c 1986 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 29.07.1987 
500 |a Date Revised 21.11.2013 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Sixty elderly patients suffering from initial mental deterioration (less than 6 months) were divided at random into two groups, homogeneous for age, sex and life habits. For 28 weeks Group I was given a placebo and Group II was given 400 mg pentoxifylline ('Trental' 400) 3-times daily for two 3-month periods interrupted by a 4-week wash-out period. Neuropsychological performance and haemorheological parameters were evaluated at the beginning and at the end of each phase of the study. The results showed that pentoxifylline medication significantly improved the psycho-intellectual performance, decreased whole blood viscosity and increased red cell filterability. The results indicate a need to concentrate further study on haemorheological factors in the clinical aspects of the ageing brain, also with a view to allowing for sufficiently long treatment periods 
650 4 |a Clinical Trial 
650 4 |a Journal Article 
650 4 |a Randomized Controlled Trial 
650 7 |a Theobromine  |2 NLM 
650 7 |a OBD445WZ5P  |2 NLM 
650 7 |a Pentoxifylline  |2 NLM 
650 7 |a SD6QCT3TSU  |2 NLM 
700 1 |a Ciuffetti, G  |e verfasserin  |4 aut 
700 1 |a Mercuri, M  |e verfasserin  |4 aut 
700 1 |a Lupattelli, G  |e verfasserin  |4 aut 
700 1 |a Senin, U  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)  |d 1995  |g 4(1986), 10 vom: 02., Seite 617-27  |w (DE-627)NLM023961570 
773 1 8 |g volume:4  |g year:1986  |g number:10  |g day:02  |g pages:617-27 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_121 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 4  |j 1986  |e 10  |b 02  |h 617-27